Home › Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in October
 

Keywords :   


Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in October

2014-08-13 07:02:43| Biotech - Topix.net

Incivek was the first approved drug for Vertex in 2011, but it was quickly overwhelmed by competition from other hepatitis C treatment, including Gilead's Sovaldi.

Tags: in october stop selling

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Atlantic Tropical Weather Outlook
30.06Eastern North Pacific Tropical Weather Outlook
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Public Advisory Number 6A
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Wind Speed Probabilities Number 6
30.06Hurricane Beryl Public Advisory Number 6
More »